DATASHEET
Host:
Rabbit
Target Protein:
NOD2
Immunogen Range:
251-350/1040
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
64127
Swiss Prot:
Q9HC29
Source:
KLH conjugated synthetic peptide derived from human CARD15
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
Defects in NOD2 are the cause of sarcoidosis early-onset (EOS) . EOS is a form of sarcoidosis manifesting in children younger than 4 years of age. Sarcoidosis is an idiopathic, systemic, inflammatory disease characterized by the formation of immune granulomas in involved organs. Granulomas predominantly invade the lungs and the lymphatic system, but also skin, liver, spleen, eyes and other organs may be involved. Early-onset sarcoidosis is quite rare and has a distinct triad of skin, joint and eye disorders, without apparent pulmonary involvement. Compared with an asymptomatic and sometimes naturally disappearing course of the disease in older children, early-onset sarcoidosis is progressive and in many cases causes severe complications, such as blindness, joint destruction and visceral involvement.
PRODUCT SPECIFIC PUBLICATIONS
- Lan Yang. et al. Lactobacillusjohnsonii L531 Protects against Salmonella Infantis-Induced Intestinal Damage by Regulating the NOD Activation, Endoplasmic Reticulum Stress, and Autophagy. INT J MOL SCI. 2022 Jan;23(18):10395Read more>>
VALIDATION IMAGES
Raji probed with CARD15 Polyclonal Antibody, ALEXA FLUOR® 488 Conjugated (bs-7084R-A488) at 1:100 for 30 minutes compared to control cells (blue)and isotype control (orange).
A549 cell lysates probed with CARD15/NOD2 Polyclonal Antibody, Unconjugated (bs-7084R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.